Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AmeriPath, Inc. Announces 1999 Fourth Quarter and Year End Results.


Business Editors

RIVIERA BEACH Riviera Beach (rəvēr`ə), resort city (1990 pop. 27,639), Palm Beach co., SE Fla., on Lake Worth (a lagoon); inc. 1922. Research and development firms are located in the growing city. , Fla.--(BUSINESS WIRE)--Feb. 22, 2000

- Quarterly Net Revenue and Net Income Up 27% and 14%, Respectively -

AmeriPath, Inc. (Nasdaq:PATH), the nation's leading integrated physician group practice and laboratory management company focused on anatomic anatomic /ana·tom·ic/ (an?ah-tom´ik) anatomical.
Anatomic
Related to the physical structure of an organ or organism.
 pathology pathology, study of the cause of disease and the modifications in cellular function and changes in cellular structure produced in any cell, organ, or part of the body by disease.  services, today reported its results for the fourth quarter and year ended December 31, 1999.

Net revenue for the quarter ended December 31, 1999 was $65.1 million, compared to $51.5 million for the fourth quarter of the prior year, an increase of 27%. Same practice net revenue for the fourth quarter of 1999 increased by $3.8 million or 7% over the fourth quarter of the prior year. The remaining increase in net revenue of $9.8 million resulted from the operations of the acquired practices. Net income for the quarter was $6.1 million, or $0.28 per share, compared to $5.3 million, or $0.25 per share, for the same period of the prior year. The diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 weighted average number of shares outstanding for the fourth quarter of 1999 were 22.1 million, compared to 21.6 million for the same period in 1998.

For the year ended December 31, 1999, AmeriPath reported net revenue of $232.8 million, an increase of 31% over the $177.3 million reported for the year ended December 31, 1998. Of this increase, $49.0 million was attributable to acquisitions. Same practice net revenue for 1999 increased by $6.5 million, or 4%. Same practice hospital net revenue increased $3.1 million, or 2% and same practice outpatient outpatient /out·pa·tient/ (-pa-shent) a patient who comes to the hospital, clinic, or dispensary for diagnosis and/or treatment but does not occupy a bed.

out·pa·tient
n.
 net revenue increased $4.2 million, or 3%. These increases were offset by a 1% Medicare Medicare, national health insurance program in the United States for persons aged 65 and over and the disabled. It was established in 1965 with passage of the Social Security Amendments and is now run by the Centers for Medicare and Medicaid Services.  reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 decrease, which was effective January 1, 1999. Net income for the year was $23.0 million, or $1.05 per share, compared to $18.6 million, or $0.89 per share, for the year ended December 31, 1998. The diluted weighted average number of shares outstanding for the year ended December 31, 1999 were 21.8 million as compared to 21.0 million for 1998. Cash flow from operations Cash flow from operations

A firm's net cash inflow resulting directly from its regular operations (disregarding extraordinary items such as the sale of fixed assets or transaction costs associated with issuing securities), calculated as the sum of net income plus noncash expenses
 for 1999 was approximately $35.1 million, compared to $21.7 million for 1998. Annualized annualized

Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared.
 net revenue per pathologist pa·thol·o·gist
n.
A specialist in pathology who practices chiefly in the laboratory as a consultant to clinical colleagues.


Pathologist 
 full-time equivalent Full-time equivalent (FTE) is a way to measure a worker's involvement in a project, or a student's enrollment at an educational institution. An FTE of 1.0 means that the person is equivalent to a full-time worker, while an FTE of 0.5 signals that the worker is only half-time.  continues at approximately $1.0 million.

James C. New, President and Chief Executive Officer of AmeriPath, commented, "AmeriPath's second year as a public company was outstanding in numerous ways. We again exceeded both Wall Street's financial expectations and our internal budgets for the ninth consecutive quarter. Our annual net revenue run rate now exceeds $270 million. During 1999, we completed 10 acquisitions and entered new markets in Georgia Georgia, country, Asia
Georgia (jôr`jə), Georgian Sakartvelo, Rus. Gruziya, officially Republic of Georgia, republic (2005 est. pop. 4,677,000), c.26,900 sq mi (69,700 sq km), in W Transcaucasia.
 and Michigan, while adding to our market penetration Noun 1. market penetration - the extent to which a product is recognized and bought by customers in a particular market
penetration - the act of entering into or through something; "the penetration of upper management by women"
 and presence in Texas, Florida, Wisconsin and Pennsylvania. Our consistent profitability and cash flow, coupled with the increase in availability under our credit facility to $230 million, provide the necessary capital to invest in technology, equipment, and to finance strategic acquisitions. For 2000, we expect that the acquisition and operational strategies that have worked for us in the past will continue to be the foundation for future growth. These strategies include quality acquisitions, market densification, high quality service, same practice revenue growth and the integration of acquired practices into AmeriPath's operating structure. In 2000, we will also make major strides toward the transition of AmeriPath into one of the country's leading providers of healthcare diagnostic information."

The Company will broadcast its fourth quarter and year ended December 31, 1999 financial results conference call on Tuesday, February 22, 2000 at 10:00 a.m. EST EST electroshock therapy.

EST
abbr.
electroshock therapy
 over the Internet. This event is available through Investor Broadcast Network's Vcall website, located at http://www.vcall.com. Listeners should go to the website at least fifteen minutes before the event to register, download To receive a file transmitted over a network. In any communications session, "download" means receive, and "upload" means send. The download/upload often implies a big/little scenario, in which data is being downloaded from the "big" server into the "little" user's computer. , and install any necessary audio software. For those unable to attend the live broadcast, a replay will be available shortly after the call. There is no charge to access the event. The replay of the call will also be available by telephone beginning at 12:00 p.m. February 22 to 12:00 p.m. February 23. The dial-in number is 800-633-8284, reservation no. 14370742.

AmeriPath, Inc. is the nation's leading physician group practice and laboratory management company focused on providing anatomic pathology services to physicians, hospitals, national clinical laboratories and managed care organizations. The Company presently operates in 13 states and employs 297 physicians that provide medical services through outpatient pathology laboratories, hospital inpatient inpatient /in·pa·tient/ (in´pa-shent) a patient who comes to a hospital or other health care facility for diagnosis or treatment that requires an overnight stay.

in·pa·tient
n.
 laboratories and outpatient surgery Outpatient Surgery, also referred to as ambulatory surgery or same-day surgery, is surgery that does not require an overnight hospital stay. The term “outpatient” arises from the fact that surgery patients may go home do not need an overnight hospital  centers.

This release contains certain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 regarding AmeriPath, including its operations and prospects. Past performance is not necessarily indicative of future results. In addition, AmeriPath's actual results could differ materially from the results anticipated in these forward-looking statements as a result of uncertainties, including risks relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 demand, pricing, government regulation, payments and reimbursements, dependence upon contracts and pathologists
  • Max Bielschowsky
  • Paul Ehrlich - (1854 - 1915)
  • Gustav Giemsa - (1867 - 1948) (see Giemsa stain)
  • Ludwig Grünwald
  • William Boog Leishman - (1865 - 1926) (see leishmaniasis)
  • Richard May
  • Frank Burr Mallory (1862 - 1941) (see Mallory bodies)
, acquisitions, integration of acquired practices, the market for pathology services, competition, and other factors identified in AmeriPath's filings with the Securities and Exchange Commission.

Editor's Note Editor's Note (foaled in 1993 in Kentucky) is an American thoroughbred Stallion racehorse. He was sired by 1992 U.S. Champion 2 YO Colt Forty Niner, who in turn was a son of Champion sire Mr. Prospector and out of the mare, Beware Of The Cat.

Trained by D.
: This release is also available at http://www.ameripath.com

                            AmeriPath, Inc.
            Condensed Consolidated Statements of Operations
                 (In thousands, except per share data)

                             Three Months Ended       Year Ended
                                 December 31,        December 31,
                                 (Unaudited)
                             ------------------  --------------------
                               1999       1998      1999       1998
                             -------  ---------  ---------  ---------
Net revenue                  $65,145  $  51,482  $ 232,753  $ 177,304
                             -------  ---------  ---------  ---------
Operating costs and
 expenses:
   Cost of services           31,587     22,571    108,177     78,460
   Selling, general & admin.
    expense                   10,074      8,850     37,590     29,731
   Provision for doubtful
    accounts                   6,716      5,811     25,262     18,698
   Amortization expense        3,607      2,629     12,453      9,461
                             -------  ---------  ---------  ---------
   Total operating costs
    and expenses              51,984     39,861    183,482    136,350
                             -------  ---------  ---------  ---------
Income from operations        13,161     11,621     49,271     40,954
Interest expense              (2,731)    (2,285)    (9,299)    (8,201)
Other income (expense), net       59        (37)       114         10
                             -------  ---------  ---------  ---------
Income before income taxes    10,489      9,299     40,086     32,763
Provision for income taxes     4,391      3,953     17,117     14,124
                             =======  =========  =========  =========
Net income                   $ 6,098  $   5,346  $  22,969  $  18,639
                             =======  =========  =========  =========

Diluted net income per share $  0.28  $    0.25  $    1.05  $    0.89
                             =======  =========  =========  =========
Diluted weighted average
 shares                       22,079     21,601     21,828     21,038
                             =======  =========  =========  =========

                            AmeriPath, Inc.
                 Condensed Consolidated Balance Sheets
                            (In thousands)

                                December 31, December 31,
                                    1999        1998

Cash and cash equivalents         $    620   $    458
Accounts receivable, net            45,969     36,090
Inventories                            482        526
Other current assets                 7,144      8,960
                                  --------   --------
    Total current assets            54,215     46,034
Property and equipment, net         14,129      8,584
                                  --------   --------
Other assets                       381,802    307,329
      Total assets                $450,146   $361,947
                                  ========   ========
Total current liabilities         $ 19,047   $ 17,442
                                  --------   --------
Revolving loan                     163,300    121,087
Subordinated notes                     777      1,106
Deferred taxes                      62,980     44,488
    Total long term liabilities    227,057    166,681

Total stockholders' equity         204,042    177,824

     Total liabilities and
      stockholders' equity        $450,146   $361,947
                                  ========   ========
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 22, 2000
Words:1135
Previous Article:Hercules Intends to Sell Resins Division, Enters Discussions With Potential Buyer.
Next Article:HotOffTheWire.com Earns TRUSTe Privacy Seal; TRUSTe Privacy Seal Granted to HotOffTheWire.com for Helping Businesses Protect Privacy and Security...
Topics:



Related Articles
AmeriPath, Inc. Announces 2000 First Quarter Results.
AmeriPath, Inc. Announces 2000 Third Quarter Results; Net Revenue Up 25% and Net Income Increases 17%.
AmeriPath, Inc. Announces 2000 Fourth Quarter and Year-End Financial Results.
Company performances in year 2000.
SPECIALTY DIAGNOSTICS COMPANY ACQUIRED FIRM'S VALENCIA OPERATIONS TO CONTINUE AFTER AGREEMENT.
SPECIALTY LABORATORIES ACQUIRED FIRM'S VALENCIA OPERATIONS TO CONTINUE AFTER AGREEMENT.
SPECIALTY DIAGNOSTICS COMPANY ACQUIRED FIRM'S VALENCIA OPERATIONS TO CONTINUE AFTER AGREEMENT.
SPECIALTY'S Q3 REVENUE CLIMBS.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles